Tag Archives: Fabry

We looked at Protalix Biotherapeutics Inc (NYSEMKT:PLX) last week as part of this piece, when the company took a hit on some misinformation regarding a data drop. That situation is behind us now, and we’re not going to bring it up again....

Protalix Biotherapeutics Inc (NYSEMKT:PLX) took a midweek hit this week, and currently trades at a little over $1 a share – down more than 20% off early week highs. The company released some data, data that we highlighted as being a key value...

At the beginning of this week, we highlighted Protalix Biotherapeutics Inc (NYSEMKT:PLX) as being a company to keep an eye on, with the highlighting rooted in the fact that management was set to hold a conference call on the back of its full-year...

Make a list of top performing biotech stocks of 2017 year to date, and Protalix Biotherapeutics Inc (NYSEMKT:PLX) is at or near the top. The company currently trades for around $1.20 a pop, having kicked off 2017 at circa $0.40 – a nearly...

On Monday, February 13, 2017, Protalix Biotherapeutics Inc (NYSEMKT:PLX) announced that it would be presenting at the 13th Annual WORLDSymposium 2017 in California. On the back of the announcement, the company gained just short of 30%, and...

At the beginning of January, we looked at Protalix Biotherapeutics Inc (NYSEMKT:PLX), in this piece. At that time, our thesis was simple, and our reason for highlighting the company – even simpler. Basically, we thought that the company was...

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter